[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

@RxRegA "Just add another line making Blenrep 3rd line and slap on a REMS and voila it's FDA approved again. Pic shows the adcomm votes"
X Link @RxRegA 2025-10-24T11:01Z 5853 followers, 1156 engagements

"@JacobPlieth Will sponsors start digging up their rejected cancer drugs for any sign of potential life in third line post hoc analyses"
X Link @RxRegA 2025-10-24T11:23Z 5853 followers, XX engagements

"@JacobPlieth My other question after my first question about what was pre-specified for testing is whether the REMS has been at all tested for ability to mitigate risk. Also what is safety in this population"
X Link @RxRegA 2025-10-24T11:39Z 5853 followers, XXX engagements

"$GSK: Here's the new blenrep (belantamab mafodotin-blmf) label I'm curious to see the approval letter and review docs which should be posted to this FDA database w/in a month"
X Link @RxRegA 2025-10-25T11:07Z 5854 followers, XXX engagements

"Reposted by Replimune's Head of a global SCIENTIFIC engagement"
X Link @RxRegA 2025-08-01T17:18Z 5854 followers, 31.8K engagements

"FDA has posted the approval letter for $GSK's Blemrep showing details of the REMS and postmarket study requirements"
X Link @RxRegA 2025-10-27T20:08Z 5853 followers, XXX engagements